Table 2.
Participants No. (%) | |
---|---|
Included in the study | 220 (100) |
Analyzed for effectiveness | 200 (91) |
Discontinued for other reasons than alopecia | 20 (9) |
Low tolerability | 4 |
Side effects | 16 |
Participants No. (%) | |
---|---|
Included in the study | 220 (100) |
Analyzed for effectiveness | 200 (91) |
Discontinued for other reasons than alopecia | 20 (9) |
Low tolerability | 4 |
Side effects | 16 |